Anti-Müllerian hormone

There are 349 papers on anti-Müllerian hormone in aging research: 23 trials and 157 observational studies in people, 71 in animals, 1 in cells, 75 reviews. The newest story, Nov 6, 2026: “Lactate-linked protein change limits death in cultured ovarian cells”.

Biomarker

349 papers study it60 more mention it231 findings

MeSH

22 new papers in 30 daysSee all 409 papers on anti-Müllerian hormone

At a glance

Lower anti-Müllerian hormone is linked with older age in human cohorts of women. A study reports prediction of menopause during the menopausal transition, and another links lower levels with lower spine bone mineral density over 14 years. A dehydroepiandrosterone trial in women reports increased levels in diminished ovarian reserve; another shows no clear effect in primary ovarian insufficiency.

231 findings in 154 papers from 2010 to 2026, 37 of them since April 2026

“the risk of early spontaneous miscarriage was 1.57 times higher in the group with AMH < 1.1 ng/ml group (P < 0.001)”
Association between ovarian reserve and spontaneous miscarriage and their shared genetic architectureHuman reproduction (Oxford, England)2023doi:10.1093/humrep/dead180
  • Human trial23
  • Humans157
  • Animals71
  • Cells1
  • In silico2

Interventions

48

Dehydroepiandrosterone

upin humans2no changein humans1upin mice1upin O. aries1+1

6 studies
  1. Dehydroepiandrosterone increases anti-Müllerian hormone in humans (diminished ovarian reserve) (p=0.001).

    “There were significant differences in day 3 FSH, oestradiol, antral follicle count, AMH and inhibin B levels before and after DHEA supplementation”

    Human trialdiminished ovarian reservesupplementation25mg, t.i.d.at least 6 weeksfemalesn = 41

    Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count

    European journal of obstetrics, gynecology, and reproductive biology

  2. Dehydroepiandrosterone showed no clear effect on anti-Müllerian hormone in humans (primary ovarian insufficiency).

    “No significant change in serum AMH and FSH levels had been detected throughout the study.”

    Human trialprimary ovarian insufficiencyserum25 mg three times a day16 wkfemalesn = 22

    A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency

    The Journal of clinical endocrinology and metabolism

  3. Dehydroepiandrosterone increases anti-Müllerian hormone in humans (diminished ovarian reserve) (approximately 60% (P<0.0002)).

    “AMH improved longitudinally by approximately 60% (P<0.0002).”

    Human trialdiminished ovarian reserve25mg three times daily30-120 daysfemalesn = 120

    Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation

    Reproductive biomedicine online

  4. Dehydroepiandrosterone showed no clear effect on anti-Müllerian hormone in rhesus monkeys (old macaques given short-term DHEA supplementation).

    “AMH concentrations within the ovaries and circulation, assessed by Western analysis and ELISA, respectively, showed significant age-related decreases that were not attenuated by DHEA supplementation”

    Animalsold macaques given short-term DHEA supplementation5 mg daily oral2.5-monthsfemalesn = 6

    Lack of effect of short-term DHEA supplementation on the perimenopausal ovary†

    Biology of reproduction

  5. Dehydroepiandrosterone increases anti-Müllerian hormone in mice (diminished ovarian reserve).

    “The E2, AMH and INHB were down-regulated in the DOR group and reversed in the DOR + DHEA group.”

    Animalsdiminished ovarian reserve

    Effects of dehydroepiandrosterone supplementation on mice with diminished ovarian reserve

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

  6. Dehydroepiandrosterone increases anti-Müllerian hormone in O. aries.

    “DHEA increased the expression of both the proliferation marker (KI-67) in granulosa cells and the follicular AMH expression at the preantral and early antral follicle stages.”

    Animalsimplantsovarian cortex10 weeksfemalesn = 6

    Effects of dehydroepiandrosterone on in vivo ovine follicular development

    Human reproduction (Oxford, England)

More on Dehydroepiandrosterone

Platelet-rich plasma

upin humans3

3 studies
  1. Platelet-rich plasma increases anti-Müllerian hormone in humans (premature ovarian insufficiency) (0.53 ± 0.34 to 0.66 ± 0.46 ng/mL).

    “Statistical analysis demonstrated a significant increase in AMH levels following PRP treatment (p ≤ 0.05).”

    Human trialpremature ovarian insufficiencyovary3 monthsfemalesn = 33

    Differences in Anti-Müllerian Hormone Levels Before and After Platelet-Rich Plasma–Based Ovarian Rejuvenation in Patients with Premature Ovarian Insufficiency

    Journal La Medihealtico

  2. Platelet-rich plasma increases anti-Müllerian hormone in humans (ovarian insufficiency).

    “there are promising reports of increased anti-Müllerian hormone levels”

    Reviewovarian insufficiency

    Ovarian Rejuvenation with Platelet-Rich Plasma (prp): Reality or Promise?

    Nursing Edição Brasileira

  3. Platelet-rich plasma increases anti-Müllerian hormone in women with diminished ovarian reserve.

    “studies reported changes in ovarian reserve markers, including increases in serum anti-Müllerian hormone (AMH) levels”

    Reviewin women with diminished ovarian reserve

    Unlocking ovarian rejuvenation with platelet-rich plasma: systematic review and proposed clinical framework for Controlled use in poor prognosis patients undergoing in vitro fertilisation

    Archives of gynecology and obstetrics

More on Platelet-rich plasma

Resveratrol

upin chickens1upin rats1

2 studies
  1. Resveratrol increases anti-Müllerian hormone in chickens (only in older hens, age-by-RES interaction).

    “Plasma levels of melatonin (MT), estradiol (E2), and anti-Müllerian hormone (AMH) also showed significant interactions (P < 0.05), with RES increasing these hormones only in older hens.”

    Animalsonly in older hens, age-by-RES interaction400 mg/kg12 weeks

    Resveratrol supplementation mitigates age-related declines in egg production, quality, and ovarian health of laying hens

    Animal nutrition (Zhongguo xu mu shou yi xue hui)

  2. Resveratrol increases anti-Müllerian hormone in aged rats versus aged untreated rats.

    “The AMH in the Aged+Res group was elevated, compared to that in Aged group (p < 0.05).”

    Animalsin aged rats versus aged untreated rats20 mg/kg/day45 daysfemales

    Resveratrol improves ovarian function in aged rat by inhibiting oxidative stress and activating the Sirt1

    General physiology and biophysics

More on Resveratrol

Smoking

downin humans2

2 studies
  1. Smoking is linked with lower anti-Müllerian hormone in humans (current smokers compared with non-smokers; former smokers also lower) (current smokers 20.3% lower (95% CI −29.2 to −10.3%); former smokers 12.7% lower (95% CI −21.2 to −3.2%)).

    “Current and former smokers had 20.3% (95% CI ‒29.2 to ‒10.3%) and 12.7% (‒21.2 to ‒3.2%) lower AMH levels, respectively”

    Humanscurrent smokers compared with non-smokers; former smokers also lowerfemales

    Exploring the association between lifestyle factors and anti-Müllerian hormone concentration and rate of decline

    Reproductive biomedicine online

  2. Smoking is linked with lower anti-Müllerian hormone in humans (compared with never use) (12% lower, P < 0.0001).

    “Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001).”

    Humanscompared with never usefemales

    Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

    The Journal of clinical endocrinology and metabolism

More on Smoking

Oral contraceptives

downin humans2

2 studies
  1. Oral contraceptives are linked with lower anti-Müllerian hormone in humans (current use compared with never use) (41.5% lower (95% CI −49.9 to −31.4%)).

    “current oral contraceptive use was associated with 41.5% (95% CI ‒49.9 to ‒31.4%) lower AMH levels”

    Humanscurrent use compared with never usefemales

    Exploring the association between lifestyle factors and anti-Müllerian hormone concentration and rate of decline

    Reproductive biomedicine online

  2. Oral contraceptives are linked with lower anti-Müllerian hormone in humans (compared with never use) (40% lower, P < 0.0001).

    “Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001).”

    Humanscompared with never usefemales

    Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

    The Journal of clinical endocrinology and metabolism

More on Oral contraceptives

Fingolimod

upin mice1upin rats1

2 studies
  1. Fingolimod increases anti-Müllerian hormone in mice.

    “In aged mice, FTY720 treatment increased follicle numbers, improved oocyte mitochondrial quality, and elevated serum AMH levels.”

    Animals

    Reprogramming the aging ovarian microenvironment via mitochondrial sharing and structural remodeling

    Theranostics

  2. Fingolimod increases anti-Müllerian hormone in rats (5.72 ± 0.61 vs 4.81 ± 0.85 ng/mL).

    “high-dose S1P group had higher mean levels of AMH, reaching marginal significance with controls (5.72 ± 0.61 vs 4.81 ± 0.85 ng/mL, P = .050)”

    Animalsoral1 mg/kg/day60 daysfemalesn = 10

    The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model

    Reproductive sciences (Thousand Oaks, Calif.)

More on Fingolimod

Sleeve gastrectomy

downin humans1

1 study
  1. Sleeve gastrectomy decreases anti-Müllerian hormone in humans (to 2.0 (± 0.2) ng/mL).

    “By 12 months, BMI fell to 25.65 (± 0.34) kg/m2, AMH to 2.0 (± 0.2) ng/mL, and AFC to 7.0 (± 1.0) and 6.0 (± 1.0) (p < 0.001).”

    Human trial12-monthfemalesn = 32

    Impact of Sleeve Gastrectomy on Obesity Indices, Reproductive Hormones, and Follicular Quality: A 12-Month Prospective Study

    Research SquarePreprint

  2. Sleeve gastrectomy decreases anti-Müllerian hormone in humans (from 3.0 to 2.0 ng/mL, p < 0.001).

    “AMH from 3.0 to 2.0 ng/mL”

    Human trial12 monthsfemalesn = 32

    Impact of Sleeve Gastrectomy on Obesity Indices, Reproductive Hormones, and Follicular Quality: A 12-Month Prospective Study

    Research SquarePreprint

More on Sleeve gastrectomy

Shift work

no changein humans1

1 study
  1. Shift work was not clearly linked with anti-Müllerian hormone in humans.

    “no significant group differences were observed in serum AMH or plasma AMH levels.”

    Humansserum and plasmafemalesn = 62

    Shift Work is Associated with Lower Total Antral Follicle Count and Changes in the Vitamin D Axis Among Young Female Physicians

    Frontiers in endocrinology

More on Shift work

Acupoint catgut embedding

upin humans1

1 study
  1. Acupoint catgut embedding increases anti-Müllerian hormone in humans.

    “In the treatment group, after 3 treatment cycles, AMH levels increased from baseline (P < 0.05).”

    Human trialDiminished ovarian reserve; combined with hormone replacement therapy; compared with baselineserum3 treatment cycles

    Efficacy and Safety of Acupoint Catgut Embedding Combined with Hormone Replacement Therapy versus Sham Acupoint Embedding Combined with Hormone Replacement Therapy for Diminished Ovarian Reserve: A Single-Blind Randomized Controlled Trial

    Combinatorial chemistry & high throughput screening

More on Acupoint catgut embedding

Bushen tiaojing decoction

no changein mice1

1 study
  1. Bushen tiaojing decoction showed no clear effect on anti-Müllerian hormone in mice (aged mice).

    “Although serum AMH level was higher in the old + BSTJD group than in the old group, the difference was not statistically significant ( P > 0.05).”

    Animalsaged miceblood20 g/(kg·d)10 consecutive weeksfemalesn = 35

    Regulation of oocyte meiosis and reproductive function by Bushen Tiaojing Decoction through the APC/C-CDC20 signaling pathway in aged mice

    Digital Chinese Medicine

More on Bushen tiaojing decoction

Ergothioneine

upin humans1

1 study
  1. Ergothioneine increases anti-Müllerian hormone in humans (suboptimal ovarian reserve) (+0.65 ng/mL (95% CI [0.14, 1.17])).

    “mean AMH increased from 1.81 ± 0.72 to 2.46 ± 1.54 ng/mL (mean change + 0.65 ng/mL, 95% CI [0.14, 1.17], p = 0.018)”

    Human trialsuboptimal ovarian reserveoralserum120 mg/daythree consecutive menstrual cyclesfemalesn = 36

    Oral L-ergothioneine supplementation in women with suboptimal ovarian reserve: a single-center, open-label, self-controlled pilot study of ovarian reserve markers, endocrine profiles, and reproductive aging-related symptoms

    BMC women's health

More on Ergothioneine

Laparoscopic sleeve gastrectomy

no changein humans1

1 study
  1. Laparoscopic sleeve gastrectomy showed no clear effect on anti-Müllerian hormone in humans (obesity) (2.2 [1.5–3.0] ng/ml to 2.5 [0.9–3.0] ng/ml).

    “Plasma AMH levels increased from 2.2 [1.5–3.0] ng/ml to 2.5 [0.9–3.0] ng/ml after LSG, but this change was not statistically significant.”

    Human trialobesity12 monthsfemalesn = 49

    The impact of laparoscopic sleeve gastrectomy on ovarian reserve markers in obese female patients of reproductive age

    Endocrine Surgery

More on Laparoscopic sleeve gastrectomy

Exercise

upin humans1

1 study
  1. Exercise increases anti-Müllerian hormone in humans (diminished ovarian reserve).

    “At post-treatment assessment, AMH levels were significantly higher in the intervention group”

    Human trialdiminished ovarian reservethree monthsfemalesn = 24

    Effects of Supervised Physiotherapy-Based Exercise on Ovarian Reserve and Spontaneous Pregnancy in Women with Diminished Ovarian Reserve: A Controlled Pilot Study

    Life (Basel, Switzerland)

More on Exercise

Er-xian decoction

upin humans1

1 study
  1. Er-xian decoction increases anti-Müllerian hormone in DOR patients.

    “serum anti-Mullerian hormone (AMH) level in DOR patients with EXD treatment was higher than that in DOR patients without EXD treatment”

    Human trialin DOR patients

    Kaempferol exerts antioxidant effects in age-related diminished ovarian reserve by regulating the HSP90/NRF2 pathway

    Chemical biology & drug design

More on Er-xian decoction

All 48

Effects

5

Follicle counts

mediatesin humans1

1 study
  1. Anti-Müllerian hormone is linked with follicle counts in humans (onto the number of follicles) (proportion mediated = 31%, p = 0.002).

    “the effect of the PGS onto the number of follicles was partly mediated by AMH levels (proportion mediated = 31%, p = 0.002).”

    Humansonto the number of folliclesfemalesn = 435

    The polygenic score for age at menopause is independently associated with the response of controlled ovarian hyperstimulation in women undergoing IVF

    EBioMedicine

More on Follicle counts

Body mass index

no changein humans1

1 study
  1. Anti-Müllerian hormone was not clearly linked with body mass index in humans.

    “AMH was not associated with BMI or insulin resistance.”

    Humansfemalesn = 670

    Serum anti-mullerian hormone levels and age among Samoan women

    Reproductive biology and endocrinology : RB&E

More on Body mass index

Age at menopause

mediatesin humans1

1 study
  1. Anti-Müllerian hormone is linked with age at menopause in humans (association of breastfeeding duration with age at menopause).

    “Breastfeeding duration was positively associated with age at menopause (P for trend = 0.01), with evidence that the association was mediated via AMH.”

    Humansassociation of breastfeeding duration with age at menopausefemales

    The association of parity and breastfeeding with anti-Müllerian hormone levels at two time points

    Maturitas

Multiple sclerosis status

no changein humans1

1 study
  1. Anti-Müllerian hormone was not clearly linked with multiple sclerosis status in humans (women with MS vs healthy controls) (0.98-fold difference (95% CI 0.69-1.37)).

    “AMH levels were similar (0.98-fold difference, 95% confidence interval [CI] 0.69-1.37, p = 0.87) in women with MS (n = 412, mean age 42.6 years) and healthy controls (n = 180, mean age 44 years)”

    Humanswomen with MS vs healthy controlsfemales

    Ovarian aging is associated with gray matter volume and disability in women with MS

    Neurology

More on Multiple sclerosis status

Probability of conception

no changein humans1

1 study
  1. Anti-Müllerian hormone was not clearly linked with probability of conception in humans (women aged 30 to 44 years trying to conceive for 3 months or less, low vs normal AMH) (65% (95% CI, 50%-75%) vs 62% (95% CI, 57%-66%) by 6 cycles).

    “women with low AMH values (<0.7 ng/mL [n = 84]) did not have a significantly different predicted probability of conceiving by 6 cycles of attempt”

    Humanswomen aged 30 to 44 years trying to conceive for 3 months or less, low vs normal AMHfemales

    Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age

    JAMA

Upstream

28

Age

downin humans7downin cynomolgus monkeys1OR 1.12

8 studies
  1. Age is linked with lower anti-Müllerian hormone in humans (β = -0.068; 95% CI [-0.117, -0.018]).

    “only age (β = -0.068; 95% CI [-0.117, -0.018]; p = 0.007) and transformed FSH (β = -3.582; 95% CI [-4.846, -2.317]; p < 0.001) remained independently associated with transformed AMH.”

    Humansserumfemalesn = 117

    Age and Follicle-Stimulating Hormone as Variables Independently Associated with Serum Anti-Müllerian Hormone in Women Attending a Tertiary Gynaecology Clinic: A Retrospective Cross-Sectional Study Using Censoring-Aware Modelling

    Metabolites

  2. Age is linked with lower anti-Müllerian hormone in humans (healthy) (r=-0.54).

    “AMH showed a strong inverse correlation with age (r=-0.54).”

    Humanshealthyserumfemalesn = 90

    Age-related decline in AMH and gonadotropin patterns in Syrian women: Preliminary population-based estimates

    Women's health (London, England)

  3. Age is linked with lower anti-Müllerian hormone in humans (systemic lupus erythematosus) (OR = 1.12(1.05–1.20), p = 0.001).

    “higher age [OR = 1.12(1.05–1.20), p = 0.001], active disease [OR = 3.87(1.56–9.62), p = 0.004], menstrual irregularities [OR = 4.56(1.95–10.65), p < 0.001]”

    Humanssystemic lupus erythematosusfemalesn = 168

    Assessment of ovarian reserve in reproductive age Indian women with lupus and determination of correlates of diminished reserve: results from a tertiary care centre

    Frontiers in Lupus

  4. Age is linked with lower anti-Müllerian hormone in humans (polycystic ovary syndrome) (P-trend<0.05).

    “Conversely, luteinizing hormone (LH), LH/FSH ratio, total testosterone, free testosterone, anti-Müllerian hormone (AMH), and HDL levels decreased (P-trend<0.05)”

    Humanspolycystic ovary syndromefemalesn = 936

    The impact of age on clinical features and fertility outcomes in patients with polycystic ovary syndrome: a secondary analysis based on the PCOSAct trial

    Frontiers in endocrinology

  5. Age is linked with lower anti-Müllerian hormone in humans (F = 88.538, p < 0.001).

    “An exponential model defined as AMH = 227,421.757 × e(-0.301 × age) was fit to describe the decline in AMH level with age.”

    Humansserumfemalesn = 288

    Impact of age and menopausal stage on serum anti-Müllerian hormone levels in middle-aged women

    Climacteric : the journal of the International Menopause Society

  6. Age is linked with lower anti-Müllerian hormone in ovulatory controls (p < 0.0001).

    “mean AMH level was significantly lower in the oldest age category (> 35 yrs) compared to both younger control groups (p < 0.0001).”

    Humansin ovulatory controlsserumfemales

    Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center

    Archives of endocrinology and metabolism

  7. Age decreases anti-Müllerian hormone in cynomolgus monkeys.

    “AMH levels throughout life showed a weak negative correlation with age.”

    Animalsfemales

    Menstrual cycles, lifespan, and anti-Müllerian hormone in cynomolgus monkeys

    Experimental animals

  8. Age decreases anti-Müllerian hormone in humans (undetectable ∼5 years before menopause).

    “After an initial increase until early adulthood, AMH concentrations slowly decrease with increasing age until becoming undetectable ∼5 years before menopause”

    Reviewfemales

    Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

    Human reproduction update

Chronological age

downin humans2

2 studies
  1. Chronological age is linked with lower anti-Müllerian hormone in humans (β = -0.123, 95% CI: -0.135 to -0.111, p < 0.001).

    “Chronological age was inversely associated with AMH (β = -0.123, 95% CI: -0.135 to -0.111, p < 0.001).”

    Humansfemalesn = 819

    Age-Adjusted Associations Between Routine Systemic Inflammatory Markers and Anti-Müllerian Hormone in Reproductive-Age Women: A Retrospective Cross-Sectional Study

    Biomedicines

  2. Chronological age is linked with lower anti-Müllerian hormone in humans (decline accelerated after 40 years of age).

    “The overall rate of AMH decline accelerated after 40 years of age.”

    Humans20 yearsfemalesn = 3,326

    Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline

    BMC medicine

Polycystic ovary syndrome

upin humans2

2 studies
  1. Polycystic ovary syndrome is linked with higher anti-Müllerian hormone in humans (44.4 vs 19.3 pmol/l).

    “Even after the age of 36 years, women with PCOS maintained relatively higher AMH levels (PCOS vs normo-ovulatory: 44.4 vs 19.3 pmol/l).”

    Humansfemales

    Asian women with PCOS have enhanced ovarian reserve and ART outcomes, even at an advanced maternal age: a model for reproductive longevity?

    Human reproduction open

  2. Polycystic ovary syndrome is linked with higher anti-Müllerian hormone in PCOS patients vs controls (7.54 ± 5.8 vs. 2.49 ± 2.0 ng/mL, p < 0.0001).

    “Serum AMH was significantly higher among PCOS patients compared to non-PCOS controls in the non-stratified sample (7.54 ± 5.8 vs. 2.49 ± 2.0 ng/mL, respectively; p < 0.0001)”

    Humansin PCOS patients vs controlsserumfemales

    Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center

    Archives of endocrinology and metabolism

More on Polycystic ovary syndrome

Infertility

no changein humans2

2 studies
  1. Infertility was not clearly linked with anti-Müllerian hormone in humans after controlling for age, body mass index, total testosterone and LH.

    “we found no differences between the 2 groups with regards to the serum levels of AMH, FSH, E2, and AFC (P > .05 for all)”

    Humansafter controlling for age, body mass index, total testosterone and LHfemales

    The status and comparison of ovarian reserve between fertile and infertile healthy Chinese women of reproductive age

    Medicine

  2. Infertility was not clearly linked with anti-Müllerian hormone in humans (fertile versus infertile populations).

    “there was no significant difference between the fertile and infertile populations in terms of AMH or AFC.”

    Humansfertile versus infertile populations

    Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population

    Human fertility (Cambridge, England)

More on Infertility

Herpesvirus serology

no changein humans1

1 study
  1. Herpesvirus serology was not clearly linked with anti-Müllerian hormone in humans (premenopausal women with systemic lupus erythematosus).

    “viral serologies showed no direct long-term impact on AMH levels.”

    Humanspremenopausal women with systemic lupus erythematosus24 monthsfemalesn = 80

    Diminished ovarian reserve in systemic lupus erythematosus: clinical, immunological, viral, and therapeutic determinants in a 24-month prospective study

    Frontiers in immunology

More on Herpesvirus serology

FMR1 premutation carrier status

downin humans1

1 study
  1. FMR1 premutation carrier status is linked with lower anti-Müllerian hormone in humans (lower in carriers).

    “Quantitative ovarian-reserve markers (AMH, oocyte yield, mature oocytes, fertilisations, usable blastocysts) were lower in carriers”

    Humansfemales

    FMR1-Associated Diminished Ovarian Reserve: Reduced Oocyte Yield Without Loss of Per-Embryo Ploidy

    Fertility and sterility

More on FMR1 premutation carrier status

Luteinizing hormone

no changein humans1

1 study
  1. Luteinizing hormone was not clearly linked with anti-Müllerian hormone in humans.

    “LH, estradiol, progesterone, and prolactin were not independently associated with AMH in the multivariable model (all p > 0.05).”

    Humansserumfemalesn = 117

    Age and Follicle-Stimulating Hormone as Variables Independently Associated with Serum Anti-Müllerian Hormone in Women Attending a Tertiary Gynaecology Clinic: A Retrospective Cross-Sectional Study Using Censoring-Aware Modelling

    Metabolites

More on Luteinizing hormone

Neutrophil-to-lymphocyte ratio

no changein humans1

1 study
  1. Neutrophil-to-lymphocyte ratio was not clearly linked with anti-Müllerian hormone in humans (age-adjusted) (β = -0.012, 95% CI: -0.222 to 0.198, p = 0.912).

    “After adjustment for age, neither CRP (β = -0.038, 95% CI: -0.085 to 0.009, p = 0.114) nor NLR (β = -0.012, 95% CI: -0.222 to 0.198, p = 0.912) was independently associated with AMH.”

    Humansage-adjustedfemalesn = 819

    Age-Adjusted Associations Between Routine Systemic Inflammatory Markers and Anti-Müllerian Hormone in Reproductive-Age Women: A Retrospective Cross-Sectional Study

    Biomedicines

More on Neutrophil-to-lymphocyte ratio

C-reactive protein

no changein humans1

1 study
  1. C-reactive protein was not clearly linked with anti-Müllerian hormone in humans (age-adjusted) (β = -0.038, 95% CI: -0.085 to 0.009, p = 0.114).

    “After adjustment for age, neither CRP (β = -0.038, 95% CI: -0.085 to 0.009, p = 0.114) nor NLR (β = -0.012, 95% CI: -0.222 to 0.198, p = 0.912) was independently associated with AMH.”

    Humansage-adjustedfemalesn = 819

    Age-Adjusted Associations Between Routine Systemic Inflammatory Markers and Anti-Müllerian Hormone in Reproductive-Age Women: A Retrospective Cross-Sectional Study

    Biomedicines

More on C-reactive protein

Menstrual irregularity

downin humans1OR 4.56

1 study
  1. Menstrual irregularity is linked with lower anti-Müllerian hormone in humans (systemic lupus erythematosus) (OR = 4.56(1.95–10.65), p < 0.001).

    “menstrual irregularities [OR = 4.56(1.95–10.65), p < 0.001], and anti-Ro60 positivity [OR = 1.89(0.92–3.88), p = 0.08] independently predicted reduced AMH”

    Humanssystemic lupus erythematosusfemalesn = 168

    Assessment of ovarian reserve in reproductive age Indian women with lupus and determination of correlates of diminished reserve: results from a tertiary care centre

    Frontiers in Lupus

All 28

Associations

96

Age

downin humans10upin humans2downin E. caballus1

13 studies
  1. Age is associated with anti-Müllerian hormone in humans.

    “Age was inversely associated with AMH levels”

    Humansfemales

    Temporal changes in serum anti-Müllerian hormone concentrations before, during, and after the COVID-19 pandemic: A retrospective study of 1799 women

    European journal of obstetrics, gynecology, and reproductive biology

  2. Anti-Müllerian hormone predicts age in humans (older than 35 years vs <=35 years) (AUC≈0.80).

    “with an AMH value of 1.8 ng/mL (AUC≈0.80; sensitivity 0.94; specificity 0.61)”

    Humansolder than 35 years vs <=35 yearsserumfemalesn = 90

    Age-related decline in AMH and gonadotropin patterns in Syrian women: Preliminary population-based estimates

    Women's health (London, England)

  3. Age is associated with anti-Müllerian hormone in humans (fertility assessment) (r = -0.30, p = 0.00).

    “demonstrated a stronger negative correlation with age (r = -0.34, p = 0.00) than anti-Müllerian hormone (r = -0.30, p = 0.00).”

    Humansfertility assessmentfemalesn = 372

    Anti-Müllerian hormone versus antral follicle count as first-choice biomarkers in a low-resource setting: A cross-sectional study in Kumasi, Ghana

    The Journal of international medical research

  4. Age is associated with anti-Müllerian hormone in infertile women (r = -0.30, P = 0.0015).

    “with AMH strongly negatively correlated with age (r = -0.30, P = 0.0015).”

    Humansin infertile women

    Comparative Assessment of FSH, LH, AMH, and TSH across Different Age Groups in Infertile Women

    Cognizance Journal of Multidisciplinary Studies

  5. Age is associated with anti-Müllerian hormone in humans (r = -0.65; p< 0.001).

    “A strong negative correlation was observed between AMH levels and age (r = -0.65; p< 0.001).”

    Humansserumfemalesn = 100

    Anti-Müllerian hormone as a predictor of ovarian reserve: Correlation with age and BMI

    International Journal of Clinical Obstetrics and Gynaecology

  6. Age is associated with anti-Müllerian hormone in humans.

    “AMH was negatively associated with age.”

    Humansfemalesn = 670

    Serum anti-mullerian hormone levels and age among Samoan women

    Reproductive biology and endocrinology : RB&E

  7. age is associated with anti-Müllerian hormone in pwMS.

    “Age was the only significant risk factor for low AMH levels in pwMS (OR 1.14 95%CI(1.00-1-31), p = 0.04)”

    Humansin pwMSfemalesn = 92

    Frequency of diminished ovarian reserve in women with multiple sclerosis in Chile: An exploratory study

    Multiple sclerosis and related disorders

  8. Age is associated with anti-Müllerian hormone in humans (undergoing an IVF/ICSI program) (r = -0.48).

    “between age and AMH level (r = -0.48, P < 0.001) of the same individual.”

    Humansundergoing an IVF/ICSI programfemalesn = 43

    Anti-Müllerian hormone independently affect mtDNA copy number in human granulosa cells

    Journal of ovarian research

  9. Age is associated with anti-Müllerian hormone in humans (Women of Indian origin attending fertility clinics).

    “We found a direct association of low AMH with increasing age, short cycles, amenorrhea and women with family history of premature menopause.”

    HumansWomen of Indian origin attending fertility clinicsfemales

    Effect of Reproductive and Lifestyle Factors on Anti-Mullerian Hormone Levels in Women of Indian Origin

    Journal of human reproductive sciences

  10. Age is associated with anti-Müllerian hormone in humans (independent effect of age on AMH in women aged 25 years and older).

    “There were independent effects of age and ethnicity on serum AMH concentrations”

    Humansindependent effect of age on AMH in women aged 25 years and olderfemales

    Ethnic discordance in serum anti-Müllerian hormone in healthy women: a population study from China and Europe

    Reproductive biomedicine online

All 13

Antral follicle count

upin humans3upin marmosets1

4 studies
  1. Antral follicle count is associated with anti-Müllerian hormone in humans (fertility assessment) (r = 0.42, p = 0.00).

    “The biomarkers were positively correlated (r = 0.42, p = 0.00).”

    Humansfertility assessmentfemalesn = 372

    Anti-Müllerian hormone versus antral follicle count as first-choice biomarkers in a low-resource setting: A cross-sectional study in Kumasi, Ghana

    The Journal of international medical research

  2. Anti-Müllerian hormone is associated with antral follicle count in humans (r = .88, P < .01).

    “AMH directly correlated (r = .88, P < .01) with AFC”

    Humansovaryfemalesn = 26

    Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age

    Endocrinology, diabetes & metabolism

  3. Anti-Müllerian hormone is associated with antral follicle count in marmosets (R2 = 0.64, p = 0.0002).

    “most strongly associated with bilateral medium antral follicle count per animal (R2 = 0.64, p = 0.0002)”

    Animalsovaryfemalesn = 57

    Circulating Anti-Müllerian Hormone Reflects the Medium Antral Follicle Pool Following Histological Redefinition of Follicle Size in the Common Marmoset (Callithrix jacchus)

    Journal of medical primatology

  4. Anti-Müllerian hormone is associated with antral follicle count in humans.

    “measurement of serum AMH is a superior test of ovarian reserve because it is highly associated with the number of antral follicles”

    Review

    Is there a place for AMH testing in Canada?

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

More on Antral follicle count

Polycystic ovary syndrome

upin humans3

3 studies
  1. Polycystic ovary syndrome is associated with anti-Müllerian hormone in humans (50 women with PCOS compared with 50 controls) (6.08 ± 1.67 vs 2.49 ± 0.80 ng/mL).

    “Women with PCOS had significantly higher anti-Müllerian hormone levels (6.08 ± 1.67 vs 2.49 ± 0.80 ng/mL)”

    Humans50 women with PCOS compared with 50 controlsfemalesn = 100

    Does Polycystic Ovary Syndrome Predispose to Premature Ovarian Insufficiency? A Comparative Study of Ovarian Reserve Markers in Reproductive-Age Women

    International Journal of Clinical Obstetrics and Gynaecology

  2. Anti-Müllerian hormone predicts polycystic ovary syndrome in humans (AMH diagnostic cutoff of 1.17 ng/mL) (AUC 0.71 (95% CI 0.60–0.83)).

    “An AMH cutoff of 1.17 ng/mL showed moderate diagnostic reliability for diagnosing PCOS in aging women, with an area under curve of 0.71 (95% CI:0.60-0.83).”

    HumansAMH diagnostic cutoff of 1.17 ng/mLfemales

    Structural and hormonal changes in the ovaries of women with polycystic ovary syndrome and healthy controls: a 13-year prospective study in an unselected population

    Reproductive biology and endocrinology : RB&E

  3. Polycystic ovary syndrome is associated with anti-Müllerian hormone in humans (PCOS compared with healthy controls at follow-up).

    “but retained higher levels of AMH, TT, FAI, and DHEAS than controls.”

    HumansPCOS compared with healthy controls at follow-up13 yearsfemales

    Structural and hormonal changes in the ovaries of women with polycystic ovary syndrome and healthy controls: a 13-year prospective study in an unselected population

    Reproductive biology and endocrinology : RB&E

  4. Polycystic ovary syndrome is associated with anti-Müllerian hormone in humans (Women of Indian origin attending fertility clinics).

    “We found a direct correlation of high AMH and women with polycystic ovary syndrome”

    HumansWomen of Indian origin attending fertility clinicsfemales

    Effect of Reproductive and Lifestyle Factors on Anti-Mullerian Hormone Levels in Women of Indian Origin

    Journal of human reproductive sciences

More on Polycystic ovary syndrome

Chronological age

downin humans2upin silico1+34% variation

3 studies
  1. Chronological age is associated with anti-Müllerian hormone in humans (Women of reproductive age undergoing AMH testing) (Pearson's r = -0.508; Spearman's rho = -0.547; p < 0.001).

    “Age showed a moderate-to-strong, significant inverse correlation with AMH (Pearson's r = -0.508, Spearman's rho = -0.547; p < 0.001)”

    HumansWomen of reproductive age undergoing AMH testingserumfemalesn = 264

    Routine Vitamin and Iron Biomarkers Do Not Explain Variation in Anti-Müllerian Hormone: Implications for Ovarian Reserve Testing in Clinical Practice

    Journal of clinical medicine

  2. Chronological age is associated with anti-Müllerian hormone in humans (Chinese women attending a reproductive center clinic) (r = -0.606; average AMH decrease of 6.2% per year).

    “Our results showed that serum AMH levels were negatively correlated with age (r = -0.606, p < .001).”

    HumansChinese women attending a reproductive center clinicserumfemalesn = 3,280

    Chronological age vs biological age: a retrospective analysis on age-specific serum anti-Müllerian hormone levels for 3280 females in reproductive center clinic

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

  3. Chronological age is associated with anti-Müllerian hormone in silico (34% of variation).

    “This model shows that 34% of the variation in AMH is due to age alone.”

    In silicofemalesn = 3,260

    A validated model of serum anti-müllerian hormone from conception to menopause

    PloS one

Menopause

downin humans2no changein humans1−87%

3 studies
  1. Anti-Müllerian hormone predicts menopause in humans (menopausal transition) (AUC 0.72).

    “Area under the curve for menopause diagnosis was 0.72 (cutoff = 0.0055 ng/mL).”

    Humansmenopausal transitionserumfemales

    Age-specific anti-Müllerian hormone reference values using an ultrasensitive assay: Associations with ovarian aging and menopausal transition symptoms

    Chinese medical journal

  2. Anti-Müllerian hormone predicts menopause in humans.

    “predicts the onset of menopause”

    Humansfemales

    THE IMPORTANCE OF HORMONAL ASSESSMENT IN MEDICINE

    International Bulletin of Medical Sciences and Clinical Research

  3. Anti-Müllerian hormone is linked with a lower risk of menopause in humans (-87%).

    “each unit increase in the AMH level could reduce the risk of menopause by 87%”

    Humans18 yearsfemalesn = 901

    Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause?

    Frontiers in endocrinology

Ovarian response

upin humans3

3 studies
  1. Anti-Müllerian hormone predicts ovarian response in humans (gonadotropin stimulation).

    “Serum AMH levels are sensitive and specific for ovarian responses during gonadotropin stimulation”

    Reviewgonadotropin stimulation

    Role of Anti-Müllerian Hormone in Female Fertility: A Review Article

    International Journal of Infertility & Fetal Medicine

  2. Anti-Müllerian hormone predicts ovarian response in humans (standard stimulation for IVF).

    “close correlation between initial serum AMH levels and ovarian response to standard stimulation for IVF”

    Reviewstandard stimulation for IVFfemales

    Developing anti-Müllerian hormone as an ovarian reserve biomarker

    Molecular human reproduction

  3. Anti-Müllerian hormone predicts ovarian response in humans (assisted reproductive technology cycles).

    “In assisted reproductive technology cycles, measurement of AMH helps to predict ovarian response and guide recombinant follicle-stimulating hormone dosing in women.”

    Reviewassisted reproductive technology cyclesserumfemales

    Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update

    Innovation (Cambridge (Mass.))

Ovarian reserve

upin humans3

3 studies
  1. Anti-Müllerian hormone predicts ovarian reserve in humans.

    “Anti-Müllerian hormone (AMH) secreted from granulosa cells of growing follicles is recognized as the most important biomarker for ovarian reserve.”

    Reviewserumfemales

    Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update

    Innovation (Cambridge (Mass.))

  2. Anti-Müllerian hormone predicts ovarian reserve in humans (ovarian reserve testing).

    “both antral follicular count and antimüllerian hormone have good predictive value and are superior to day-3 follicle-stimulating hormone.”

    Reviewovarian reserve testing

    Ovarian reserve testing: a user's guide

    American journal of obstetrics and gynecology

  3. Anti-Müllerian hormone predicts ovarian reserve in humans.

    “Individual AMH serum concentration does accurately reflect the size of the pool of antral follicles, representing the quantity of the remaining primordial follicles.”

    Reviewfemales

    Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

    Human reproduction update

Body mass index

upin humans1downin humans1

2 studies
  1. Body mass index is associated with anti-Müllerian hormone in humans.

    “whereas BMI showed a weak positive association.”

    Humansfemales

    Temporal changes in serum anti-Müllerian hormone concentrations before, during, and after the COVID-19 pandemic: A retrospective study of 1799 women

    European journal of obstetrics, gynecology, and reproductive biology

  2. Anti-Müllerian hormone is associated with body mass index in healthy and suspicious groups.

    “AMH was inversely correlated with BMI in healthy and suspicious groups, but not in PCOS.”

    Humansin healthy and suspicious groupsfemales

    Anti-Müllerian Hormone and Metabolic-Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population-Based Study

    Endocrinology, diabetes & metabolism

More on Body mass index

Metabolic syndrome

upin humans2OR 2.6

2 studies
  1. Anti-Müllerian hormone is linked with a higher risk of metabolic syndrome in women with PCOS (OR: 2.6, 95% CI: 1.20-6.20).

    “In contrast, among women with PCOS aged < 35 years, elevated AMH was associated with 2.6-fold higher odds of MetS (OR: 2.6, 95% CI: 1.20-6.20).”

    Humansin women with PCOSfemales

    Anti-Müllerian Hormone and Metabolic-Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population-Based Study

    Endocrinology, diabetes & metabolism

  2. Metabolic syndrome is associated with anti-Müllerian hormone in humans (cross-sectional analysis) (mean difference 0.085 (95% CI 0.035 to 0.134)).

    “except for a modest association between metabolic syndrome and AMH (mean difference 0.085; 95% CI: 0.035 to 0.134)”

    Humanscross-sectional analysisfemalesn = 829

    Ovarian aging, cardiovascular risk and inflammation: insights from the OVA study

    Journal of ovarian research

More on Metabolic syndrome

Clinical pregnancy

upin humans2OR 1.284

2 studies
  1. Anti-Müllerian hormone predicts clinical pregnancy in humans (medically assisted reproduction) (AUC = 0.62-0.69).

    “demonstrates potential predictive value in women over 35 years of age, with its predictive capacity increasing notably with age (AUC = 0.62-0.69).”

    Humansmedically assisted reproductionfemalesn = 4,891

    Predictive value of AMH in late reproductive age: a retrospective cohort study

    Scientific reports

  2. Anti-Müllerian hormone predicts clinical pregnancy in humans (infertile women undergoing IVF/ICSI) (OR 1.284, 95% CI 1.031–1.599).

    “There was significant relationship between FF AMH levels and probability of clinical pregnancy in patients older than 35 years (OR=1.284, 95%CI=1.031-1.599, P=0.026).”

    Humansinfertile women undergoing IVF/ICSI

    Predict Value of Relative Telomere Length, TERT, and Follicular Fluid Anti-mullerian Hormone Levels for IVF Outcome in Infertile Women

    Research SquarePreprint

All 96

Funding

1 grant since 2025

National Institute of Child Health and Human Development$416K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Anti-Müllerian hormone levels decline with age in human observational studies, and a study during the menopausal transition reports that it predicts menopause. Other human studies associate its levels with vascular age, osteoporosis, and menopausal symptoms.

  2. Summary rewritten as its findings changed.

    As it read before

    In human females, anti-Müllerian hormone correlates with age, body mass index, and the COVID-19 pandemic, and predicts ovarian sensitivity to exogenous gonadotropins during IVF/ICSI cycles. Reviews also link sickle cell anemia to reduced levels.

  3. Summary written from the findings.

Latest

Dec 2025: 11Jan 2026: 9Feb 2026: 15Mar 2026: 17Apr 2026: 9May 2026: 8Jun 2026: 16Jul 2026: 9Aug 2026: 19Sep 2026: 9Oct 2026: 17Nov 2026: 6145 papers in 12 months
Journal of Translational Medicine

Lactate-linked protein change limits death in cultured ovarian cells

A lactate-based protein modification supported transport channels and reduced cell death in experiments with lab-grown granulosa cells, which support developing eggs.A lactate-based protein modification supported transport channels and reduced cell death in experiments with lab-grown granulosa cells, which support developing eggs.

Human cell studyReproductive system

See all 409 papers on anti-Müllerian hormone